miR-216b-5p is Down-Regulated in Human Breast Cancer and Inhibits Proliferation and Progression by Targeting HDAC8 Oncogene
Mohammad-Nazir Menbari, Karim Rahimi, Abbas Ahmadi, Samira Mohammadi-Yeganeh, Anvar Elyasi, Nikoo Darvishi, Vahedeh Hosseini, Mohammad Abdi
This study shows miR-216b-5p is down-regulated in breast cancer and inhibits proliferation by targeting HDAC8, with lower miR-216b-5p levels linked to lymph node metastasis and larger tumor size.
bioRxiv · Dec 19, 2018 · PreprintCancer Biology